Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1752-50
Dosage Form
Injection
Presentation
Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)
Initial Posting
Feb 20, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.